Daniel A. Giannini

Daniel A. Giannini is a declared insider of NxStage Medical, Inc., with filings sourced from SEC (Form 4). We count 39 filings; the first trade dates from 29 June 2007 and the latest from 21 February 2019.

No open-market purchase appears, only 2 sales worth €283k. The rest of the record consists of 27 share grants and 9 option exercises.

The newest entry dates from 25 February 2019: a transaction of €2.2M, in NxStage Medical, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.